You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 12, September 24, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Oncology
 •Colon Cancer
 •Surgery
 •Surgical Interventions
 •Colorectal Surgery
 •Screening
 •Gastroenterology
 •Gastrointestinal Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Colorectal Cancer Risk

Black, White, or Shades of Gray?

Hemant K. Roy, MD; Laura K. Bianchi, MD

JAMA. 2008;300(12):1459-1461.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Colorectal cancer screening may affect public health through both early diagnosis and actual cancer prevention via identification and colonoscopic removal of precursor lesions (adenomatous polyps).1 However, currently only half of the eligible population undergoes colorectal cancer screening.2 Moreover, many of these patients undergo evaluation with tests that are insensitive for detecting adenomatous polyps. Therefore, despite being eminently preventable, colorectal cancer still ranks as the second leading cause of cancer deaths in the United States.1

Traditional approaches to screening dichotomize the population into increased-risk (eg, personal or family history or conditions such as ulcerative colitis) or average-risk (≥50 years) groups. The most recent guidelines categorize the available screening options as those that primarily identify cancers vs those that may also detect adenomas (with implications for colorectal cancer prevention).1 Generally, tests with higher patient acceptability lack sensitivity, whereas the more accurate tests are . . . [Full Text of this Article]

Author Affiliations: Department of Internal Medicine, Evanston Northwestern Healthcare, Evanston, Illinois.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Colonoscopy Screening in Black and White Patients
Donald A. Barr
JAMA. 2009;301(8):827-828.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Prevalence of Colon Polyps Detected by Colonoscopy Screening in Asymptomatic Black and White Patients
David A. Lieberman, Jennifer L. Holub, Matthew D. Moravec, Glenn M. Eisen, Dawn Peters, and Cynthia D. Morris
JAMA. 2008;300(12):1417-1422.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Colonoscopy Screening in Black and White Patients
Barr
JAMA 2009;301:827-828.
FULL TEXT  

Race, Sex, and Age Differences in the Prevalence of Colon Polyps
JWatch General 2008;2008:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.